![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.161.971 ![]() |
Chemical and physical data | |
Formula | C7H9NO6 |
Molar mass | 203.150 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
DCG-IV is a research drug which acts as a group-selective agonist for the group II metabotropic glutamate receptors (mGluR2/3).[1] It has potent neuroprotective and anticonvulsant effects in animal studies,[2][3][4][5] as well as showing anti-Parkinsonian effects,[6][7] but also impairs the formation of memories.[8][9]
![]() | This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |